Enteral Feeding Formula Market Report 2026

The enteral feeding formula market size has grown rapidly in recent years. It will grow from $7.09 billion in 2025 to $7.81 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing icu admissions, rising prevalence of chronic diseases, growth in aging population, expansion of hospital infrastructure, higher awareness of clinical nutrition.

The enteral feeding formula market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growth in home healthcare nutrition, increasing cancer and neurological disorder cases, rising demand for personalized nutrition, technological advances in feeding tubes and pumps, expanding healthcare access in emerging economies. Major trends in the forecast period include rising demand for disease-specific enteral formulas, increasing use of high-protein and specialized nutrition, growth in pediatric enteral nutrition adoption, expanding use of enteral feeding in home care settings, innovation in taste, texture, and tolerance improvement.

The growing demand for home care services is expected to drive the growth of the enteral feeding formulas market in the coming years. Home care services encompass a broad range of supportive services for individuals who require help with daily activities while remaining in their own homes. Enteral feeding is increasingly adopted in home-based care settings for patients who need long-term nutritional support. For example, in November 2024, according to the US Bureau of Labor Statistics, a US-based federal agency, New York recorded 60 home health and personal care aide jobs per 1,000 people in May 2023, which was 2.5 times higher than the national average of 24 per 1,000. Therefore, the rising demand for home care services is driving the growth of the enteral feeding formulas market.

Leading companies operating in the enteral feeding formulas market are developing technologically advanced products, such as enteral feeding pumps, to strengthen their product portfolios. An enteral feeding pump is a medical device used to administer liquid nutrition directly into a patient’s stomach or intestines through a feeding tube, ensuring accurate and controlled nutrient delivery for individuals who cannot consume food orally. For instance, in September 2023, Cardinal Health, a US-based healthcare company, introduced the Kangaroo OMNI enteral feeding pump. This device is designed to offer enteral feeding patients greater flexibility based on individual needs, featuring portability and versatility to deliver thick formulas and hydration across multiple care environments. It includes enhanced water resistance, allowing cleaning under running water, and is compatible with accessories such as a pole clamp and table stand. Additionally, the pump supports screen display in 19 different languages.

In May 2024, Danone, a France-based food and beverage company, acquired Functional Formularies for an undisclosed amount. Through this acquisition, Danone aims to expand its offerings for individuals with specialized medical needs, particularly within the enteral tube-feeding segment. By integrating Functional Formularies’ differentiated product portfolio, which complements Danone’s existing Real Food Blends range, the company is better positioned to address the nutritional requirements of tube-fed patients and their families. Functional Formularies is a US-based provider of enteral feeding formulas.

Major companies operating in the enteral feeding formula market are Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, B. Braun Melsungen AG, Meiji Holdings Co. Ltd., Real Food Blends, Ajinomoto Cambrooke Inc., Otsuka Pharmaceutical Co. Ltd., Medtrition Inc., Nutri-Force Nutrition, Global Health Product Inc., VICTUS, Kate Farms, Baxter International Inc., Perrigo Nutritionals LLC, Reckitt Benckiser Group plc, Bio-Serv Inc., Nutrabalace Ltd., Med-Diet Laboratories Inc., Precision Foods-Kent Corporation, SimplyThick LLC, Vitaflow LLC.

North America was the largest region in the enteral feeding formula market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enteral feeding formula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enteral feeding formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the enteral feeding formula market by increasing costs of imported raw materials, specialized nutrients, and packaging components used in formula production. this has raised pricing pressure on disease-specific and high-protein formulas, particularly affecting hospitals and long-term care facilities in import-dependent regions such as asia-pacific and latin america. however, tariffs are also encouraging local manufacturing, regional sourcing of ingredients, and capacity expansion in domestic markets, supporting supply chain resilience and long-term market stability.

The enteral feeding formula market research report is one of a series of new reports that provides enteral feeding formula market statistics, including enteral feeding formula industry global market size, regional shares, competitors with a enteral feeding formula market share, detailed enteral feeding formula market segments, market trends and opportunities, and any further data you may need to thrive in the enteral feeding formula industry. This enteral feeding formula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Enteral feeding formulas are nutritional preparations that contain specific nutrients tailored to meet the needs of consumers. Patients in intensive care or those who are unable to swallow food require targeted nutritional support. Enteral feeding formulas help meet these nutritional requirements by delivering essential nutrients directly to the patient’s stomach or small intestine.

The primary products in the enteral feeding formulas market include standard formulas and disease-specific formulas. Standard feeding formulas are designed for individuals with normal digestive function and contain all the nutrients necessary to maintain overall health. These formulas are available for both adult and pediatric stages. Enteral feeding formulas are used across applications such as oncology, gastroenterology, neurology, diabetes, critical care, and other areas. Hospitals and long-term care facilities serve as the main end users of enteral feeding formulas.

The enteral feeding formulas consists of sales of diabetic formula, renal formula, hepatic formula, pulmonary formula and peptide-based formula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.